Global health care goals for the poor not being met, Beijing conference is told

5 November 2007

This year's Global Forum for Health Research, held in Beijing, China, heard the hosting nation's Health Minister, Chen Zhu, open the four-day meeting by telling delegates that more investment is being channelled into strengthening disease prevention and control, as well as to expedite the development of health services in both rural and urban communities, as he noted that resources are unequally spread between them.

World Health Organization Director General Margaret Chan said public health depends on research in many areas, including inventing new drugs and vaccines, and establishing a health care system that offers quality and equal access for all. She added: "we are at the mid-point in the countdown to 2015...We have to face the reality. Of all the goals, those directly related to health care are the least likely to be met."

Also, Foundation Council of Global Forum for Health Research chairperson Pramilla Senanayake said, however, that the last 20 years have also seen global inequities in research. Dr Senanayake pointed out that only a fraction of the $126.0 billion that was spent on health R&D worldwide in 2003 focused on the poor.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight